Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA066781-02
Application #
2110248
Study Section
Special Emphasis Panel (ZRG3-ET-2 (02))
Project Start
1995-04-07
Project End
1998-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903

  Publications

Chu, M Y; Lipsky, M H; Yee, L K et al. (1998) Predictive sensitivity of human cancer cells in vivo using semipermeable polysulfone fibers. Pharmacology 56:318-26
Pizzorno, G; Yee, L; Burtness, B A et al. (1998) Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor. Clin Cancer Res 4:1165-75
Yee, L K; Chu, E; Pan, B C et al. (1998) Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines. Pharmacology 56:80-91
Vestal, R E; Calabresi, P (1997) Geriatric clinical pharmacologist and medical oncologist: a new partnership? Clin Pharmacol Ther 62:361-4